Jinghua Pharmaceutical Hits Day Low at CNY 6.72 Amid Price Pressure

Jinghua Pharmaceutical Group Co., Ltd. experienced a significant decline in its stock performance today, with a loss of 9.96% as of March 23, 2026. The stock reached an intraday low of CNY 6.72, reflecting a challenging trading environment for the small-cap pharmaceutical company. In terms of performance metrics, Jinghua's one-day performance stands at -8.13%, underperforming the China Shanghai Composite, which fell by 3.63%. Over the past week, the stock has dropped by 11.83%, and its one-month performance shows a decline of 10.2%. Year-to-date, Jinghua has seen a decrease of 6.61%, contrasting sharply with the broader market's performance. The company's financial indicators reveal a return on equity of 9.14% and a price-to-book ratio of 2.19, suggesting a fair valuation amidst its current challenges. Additionally, the stock has a dividend yield of 1.03%. Despite these metrics, Jinghua has underperformed the market over the past year, generating a return of only 2.03% compared to the China Shanghai Composite's 16.08%.